Increase in the duration of antidepressant treatment from 1994 to 2003: a nationwide population‐based study from Finland
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objective: We examined the length and continuity of antidepressant treatment and factors associated with long‐term of treatment among adults. Methods: Nationwide data from all reimbursed antidepressant prescriptions in 1994–2003 were linked with patients' data retrieved from Statistics Finland and the Finnish Hospital Discharge Register. Logistic regression models were used to analyse long term use of antidepressants. Results: The annual prevalence of antidepressant use increased from 3.6% in 1994 to 7.3% in 2003. Short‐term use (<3 months) decreased from 58% in 1995 to 51% in 2000 and long‐term treatment (≥12 months) increased from 18 to 21%. In 2000, 31% of treatment periods lasted ≥6 months and 24% ≥9 months. Long‐term treatment correlated to the purchase of other psychotropics, in‐patient psychiatric care, and prescription by a psychiatrist. Conclusions: Treatment periods with antidepressants have become longer over time. Clinical factors related to mental disorder severity predict long‐term use. Only a quarter had the treatment duration recommended by clinical guidelines for depression. Copyright © 2010 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 2×
“A systematic review concluded that antidepressants halve the risk of depressive relapse.(7) The optimum length of therapy, however, is not clear.”
BackgroundContinuity of antidepressant treatment for adults with depression in the United States
Olfson, M., Marcus, S. C., Tedeschi, M., & Wan, G. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.101 · Cited by 392
Moore, M., Yuen, H. M., Dunn, N., Mullee, M. A., Maskell, J., & Kendrick, T. (2009) · BMJ · doi:10.1136/bmj.b3999 · Cited by 287
The Burden of Major Depression Avoidable by Longer-term Treatment Strategies
Vos, T., Haby, M. M., Barendregt, J. J., Kruijshaar, M., Corry, J., & Andrews, G. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1097 · Cited by 213 · cited 1×
“An Australian study estimated that if treatment is continued for 6months after the remission, the overall burden of depression (measured by disability-adjusted life-years) could be reduced by about 28%.(13) Patients from lower socioeconomic groups and those receiving treatment from a physician with a high prescribing…”
BackgroundAntidepressant drug prescribing among elderly subjects: a population-based study
Percudani, M., Barbui, C., Fortino, I., & Petrovich, L. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1259 · Cited by 50
Cited by
Influences on antidepressant prescribing trends in the UK: 1995–2011
Mars, B., Heron, J., Kessler, D., Davies, N. M., Martin, R. M., Thomas, K. H., & Gunnell, D. (2017) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1306-4 · Cited by 419
Verhaak, P. F. M., de Beurs, D., & Spreeuwenberg, P. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024051 · Cited by 45
Scholten, W., Batelaan, N., & Van Balkom, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320933404 · Cited by 17
Metadata
- Authors
- Sihvo, S., Wahlbeck, K., McCallum, A., Sevon, T., Arffman, M., Haukka, J., Keskimäki, I., & Hemminki, E.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2010-09-16
- Volume
- 19
- Issue
- 11
- Pages
- 1186-1193
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2109886986
- Cited by
- 41
- References
- 5
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increase in the duration of antidepressant treatment from 1994 to 2003: a nationwide population‐based study from Finland. https://app.cochat.ai/papers/10.1002/pds.2017
- The paper
- Sihvo, S., Wahlbeck, K., McCallum, A., Sevon, T., Arffman, M., Haukka, J., Keskimäki, I., & Hemminki, E. (2010). Increase in the duration of antidepressant treatment from 1994 to 2003: a nationwide population‐based study from Finland. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.2017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.